Yuedi Hu

Ms. Yuedi Hu


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications


1 October 2023 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
YHYuedi Hu
Yuedi Hu
JLJian Liu
Jian Liu
LXLing Xin
Ling Xin
LWLei Wan
Lei Wan
YQYajun Qi
Yajun Qi
YCYiming Chen
Yiming Chen
Purpose: The therapeutic effects of Huangqin Qingre Chubi (HQC) in rheumatoid arthritis (RA) have been documented. However, there is a lack of real-world clinical evidence supporting its efficacy. Methods: Patients diagnosed with RA were recruited from the First Affiliated Hospital of the Anhui University of Chinese Medicine. Patient information was obtained from the hospital’s database. Propensity score matching (PSM), Kaplan–Meier curve, and Cox proportional hazards model were used to control confounding factors and analyze the factors influencing readmission. Association rule analysis and random walk evaluation models were used to evaluate the correlations among HQC treatment, inflammation indicators, and self-perception of patients (SPP) scale. Results: After PSM, 3423 patients were enrolled, with 1142 in the HQC group and 2281 in the non-HQC group. The readmission risk of the HQC group was significantly lower than that of the non-HQC group. Combined univariate and multivariate analysis results revealed that risk factors for readmission were age > 60 years, female sex, hypertension, chronic gastritis, and elevated levels of laboratory indices, including anticyclic citrullinated peptide and complement component 3 (C3) and C4. HQC, disease-modifying antirheumatic drugs, nonsteroidal anti-inflammatory drugs, and glucocorticoid therapy were protective factors for readmission. HQC treatment was closely associated with improvements in many factors, including erythrocyte sedimentation rate, C-reactive protein, C3, rheumatoid factor levels, visual analog scale, depression self-assessment scale, and patient-reported activity index scores with RA. Conclusion: HQC treatment can reduce the risk of readmission and significantly improve immune inflammatory indicators and SPP in patients with RA, with no risk of hepatorenal toxicity.

1 October 2023 in Journal of Inflammation Research
Verified
Journal Article
Open access
PDF file
YCYiming Chen
Yiming Chen
JLJian Liu
Jian Liu
YLYang Li
Yang Li
CCChengzhi Cong
Chengzhi Cong
YHYuedi Hu
Yuedi Hu
QHQi Han
Qi Han
Since the incidence of gouty arthritis (GA) exhibits yearly increases, accurate assessment and early treatment have significant values for improving disease conditions and monitoring prognosis. Neutrophil to lymphocyte ratio (NLR) is a common indicator in blood routine, which has the characteristics of easy access and low cost. In recent years, NLR has been proven to be an effective indicator for guiding the diagnosis, treatment, and prognosis of various diseases. Moreover, NLR has varying degrees of relationship with various inflammatory biomarkers, which can affect and reflect the inflammatory response in the body. This paper reviews the independent value of NLR for GA and its underlying molecular pathological mechanisms, intending to contribute to the further application of NLR.

19 September 2025 in Medicine
Verified
Journal Article
Open access
YLYang Li
Yang Li
JLJian Liu
Jian Liu
YHYuedi Hu
Yuedi Hu
CCCheng-zhi Cong
Cheng-zhi Cong
YCYiming Chen
Yiming Chen
FWfanfan Wang
fanfan Wang
The aim of this study was to elucidate the research direction and application value of neutrophil-to-lymphocyte ratio (NLR) as an emerging inflammatory marker in rheumatoid arthritis (RA) from both literature and clinical perspectives. Firstly, we made an extensive analysis in terms of the number of publications, highly cited literature, co-cited references, and keywords. Subsequently, a retrospective exploration of clinical data of 1490 patients with rheumatic diseases admitted to the First Affiliated Hospital of Anhui University of Chinese Medicine was conducted. Logistic regression models were used to explore the independent predictive role of NLR in different scenarios. Nomogram was developed and the model was clinically evaluated by recipient operating characteristic (ROC) curves, calibration plots and decision curve analysis. In addition, association rule analysis and Mantel test were used to determine associations between NLR and clinical characteristics and self-perception of patients. A total of 544 articles were retrieved, focusing on the pathophysiology and clinical studies of RA-NLR, such as “disease activity,” “inflammation” and “classification.” Retrospective analysis demonstrated that NLR, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were significantly higher in RA patients than in non-RA patients. Logistic regression models identified gender, age, NLR, ESR and CRP as independent predictors of RA. The ROC curve determined a cutoff value of 2.258 for NLR and a maximum area under the curve of 0.736. Both association rule analysis and Mantel test showed that NLR was highly correlated with inflammatory markers such as ESR, CRP, and self-perception scale scores before and after treatment. NLR > 2.258 was a meaningful risk factor for moderate-to-severe pain and higher disease activity, which predictive reliability was further confirmed in subgroup stratification analyses. NLR, as a novel inflammatory marker, correlates with clinical characteristics and self-perception of RA patients, acting as an independent predictor of RA diagnosis and activity assessment.

1 February 2024 in International Journal of General Medicine
Verified
Journal Article
Open access
PDF file
YCYiming Chen
Yiming Chen
JLJian Liu
Jian Liu
CCChengzhi Cong
Chengzhi Cong
YLYang Li
Yang Li
YHYuedi Hu
Yuedi Hu
Objective: This study aimed to evaluate the effect of traditional Chinese medicine (TCM) on endpoint events in patients with gouty arthritis (GA). Methods and Materials: A total of 2091 hospitalized GA patients were followed up by telephone, and propensity score matching (PSM) was used to reduce potential bias in the study design. Cox proportional risk model and Kaplan-Meier survival curve were utilized to analyze the impact and time effect of factors on the readmission of GA patients. The differences of laboratory indexes before and after treatment between the low and high exposure groups were compared, and the types and frequencies of medicines in all patients were counted. Association rule analysis was performed to investigate the association between TCM and test indexes or endpoint events. Results: After 1:1 PSM, 187 patients were enrolled in the TCM group and 187 patients in the non-TCM group. The incidence of readmission, new tophus, and all-cause death was lower in the TCM group than that in the non-TCM group (P < 0.05). Cox proportional risk regression analysis showed that TCM, NSAIDs and uric acid lowering drug were independent protective factors for GA readmission. The protective effect was enhanced by the prolongation of TCM treatment and the drug combinations. Kaplan-Meier survival curves indicated a significantly lower readmission rate in the high exposure group than in the low exposure group (P < 0.01). Compared with before treatment, NLR, hs-CRP, UA, TC and other laboratory indexes of the low and high exposure groups were improved after treatment (P < 0.01); The improvement of TG and TC in the high exposure group was more significant than the low exposure group (P < 0.01). The analysis of medicines used by all patients identified the top 20 Chinese herbal medicines and the top 2 Chinese patent medicines. The core drugs identified through association rule analysis that can improve test index and reduce the incidence of endpoint events include Yiyiren, Danshen, and HQC, among others. The network diagram of association rule analysis intuitively shows the relationship between core drugs and “improvement of indicators” and “the absence of endpoint events”. Conclusion: TCM is associated with a reduced incidence of endpoint events in patients with GA.